Barry R Davis
Overview
Explore the profile of Barry R Davis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
4844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunn J, Davis B, Matarazzo A, Willett Y, Al-Farauki S, Maki D, et al.
Am J Med
. 2024 Oct;
138(2):185-189.
PMID: 39357693
During the past decade, growing recidivism has threatened the enormous beneficial impacts of vaccinations in the United States. The barriers are multifactorial and include increasing vaccine hesitancy. The continuing dedicated...
2.
Chen V, Davis B, Kapadia S, Kattan M, Tereshchenko L
Am J Cardiol
. 2024 Sep;
231:1-10.
PMID: 39243877
In modern clinical practice, less than half of patients with new-onset heart failure (HF) undergo ischemic evaluation and only a minority undergo revascularization. We aimed to assess the proportion of...
3.
Davis B, Hennekens C, Greenwald J, Dunn J, Matarazzo A, Benson K, et al.
Am J Med
. 2024 Aug;
137(12):1154-1156.
PMID: 39089434
No abstract available.
4.
5.
Yamal J, Martinez J, Osani M, Du X, Simpson L, Davis B
JAMA Netw Open
. 2023 Dec;
6(12):e2344998.
PMID: 38048133
Importance: The long-term relative risk of antihypertensive treatments with regard to mortality and morbidity is not well understood. Objective: To determine the long-term posttrial risk of primary and secondary outcomes...
6.
Du X, Martinez J, Yamal J, Simpson L, Davis B
Front Cardiovasc Med
. 2023 Dec;
10:1272385.
PMID: 38045916
Purpose: This study aimed to determine the 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drug use. Methods: This is a post-trial passive follow-up...
7.
Juraschek S, Hu J, Cluett J, Ishak A, Mita C, Lipsitz L, et al.
JAMA
. 2023 Oct;
330(15):1459-1471.
PMID: 37847274
Importance: There are ongoing concerns about the benefits of intensive vs standard blood pressure (BP) treatment among adults with orthostatic hypotension or standing hypotension. Objective: To determine the effect of...
8.
Bidel Z, Nazarzadeh M, Canoy D, Copland E, Gerdts E, Woodward M, et al.
Hypertension
. 2023 Jul;
80(11):2293-2302.
PMID: 37485657
Background: Whether the relative effects of blood pressure (BP)-lowering treatment on cardiovascular outcomes differ by sex, particularly when BP is not substantially elevated, has been uncertain. Methods: We conducted an...
9.
Ye J, Lai D, Moye L, Davis B
Commun Stat Case Stud Data Anal Appl
. 2023 May;
8(4):728-737.
PMID: 37181862
CCTRN is a Cardiovascular Cell Therapy Research Network. There were three randomized double blinded controlled stem cell clinical trials conducted in its first phase. The main results of these three...
10.
Ghosh A, Chan W, Younes N, Davis B
Am J Epidemiol
. 2022 Dec;
192(4):621-631.
PMID: 36549905
Recurrent events can occur more than once in the same individual; such events may be of different types, known as multitype recurrent events. They are very common in longitudinal studies....